4-[5-(chloromethyl)-1,2,4-oxadiazol-3-yl]pyridine, 95.0%, 5g

(2S,4R)-1-((S)-2-((tert-butoxycarbonyl)amino)non-8-enoyl)-4-hydroxypyrrolidine-2-carboxylic acid, 98%, 250mg

5',5'''-Bis(4-carboxyphenyl)-5''-(4,4''-dicarboxy-[1,1':3',1''-terphenyl]-5'-yl)-[1,1':3',1'':3'',1''':3''',1''''-quinquephenyl]-4,4''''-dicarboxylic acid, 98%, 250mg

[(6-methoxypyridin-2-yl)methyl](methyl)amine, 95.0%, 250mg

2-Chloro-4,6-dimethoxyaniline, 97.0%, 5g

1,4-Dibromo-2-butanol>95.0%(GC)5g

2-Aminohexane, 1g

di-sodio idrogeno fosfato diidrato, 25 kg

ETHYL 2-METHYLBENZOATE, 97.0%, 500g

1-tert-Butyl 4-methyl 4-allylpiperidine-1,4-dicarboxylate, 95.0%, 100mg

Sodium 1-Heptanesulfonate [Reagent for Ion-Pair Chromatography]>98.0%(T)100g

Bismuth(III) bromide, 98%, 100g

5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid, 98.0%, 10g